THRODAHL MARK C (President and CEO) received a stock award from ORTHOPEDIATRICS CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/11/2024ACC: 0001425450-24-000069
DirectorOfficer· President and CEO
Since Feb 2019
+21.62K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
21.62K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21.62K
Price / share
—
Trade value
—
% of position
15.7%
6/11/2024
137.86K→159.48K
Total
Net shares
+21.62K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2024 | A · Award | +21.62K | — | — | 15.7% | 137.86K | 159.48K |
| Total | +21.62K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned22.50K
Total
22.50K indirect22.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 22.50K | Indirect |
| Total | 22.50K | 22.50K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported